Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

IMMUNOHEMATOLOGY - LECTINS - ANVISA Registration 10154450104

Access comprehensive regulatory information for IMMUNOHEMATOLOGY - LECTINS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10154450104 and manufactured by FRESENIUS HEMOCARE BRASIL LTDA.. The registration is held by FRESENIUS HEMOCARE BRASIL LTDA. with validity until Oct 27, 2034.

This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including DOMINION BIOLOGICALS LIMITED, LORNE LABORATORIES LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
3 Competitors
5 Recent Registrations
10154450104
Registration Details
ANVISA Registration Number: 10154450104
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

FAMรLIA DE LECTINAS
Risk Class III

Registration Details

10154450104

25351030524200416

49601107000184

Company Information

Brazil
PT: BRASIL

Dates and Status

Oct 27, 2004

27/10/2034

09/18/2025 19:00:01